Topics in Infectious Diseases, Pharmacology and Cannabinoid Medicine: An Interprofessional Update is organized by Continuing Education, Inc. and will be held from Jul 07 - 19, 2023 at Celebrity Apex, Amsterdam, North Holland, Netherlands.

Program Purpose:
This educational activity will provide guidance to improve the diagnosis, prevention, and treatment of infectious diseases. This interprofessional activity includes clinical topics, updated guidelines, and pharmacological principles and practice. Learners will leave this activity with new skills and strategies to work with the interprofessional healthcare team to prevent and improve outcomes in patients. Interactive learning will include photo-based quizzes and Jeopardy

• New antimicrobial agents and antimicrobial prophylaxis for the prevention of infective endocarditis
• Utilize up-to-date information regarding indications and usage of new antimicrobials
• Develop a reasoned approach to considering antimicrobial prophylaxis per American Heart Association guidelines

• Confusing diagnostics in infectious diseases
• Discuss how infectious disease tests are reported
• Appropriately use and interpret some newer molecular tests for infectious diseases

• Intraabdominal infections and diverticulitis
• Describe the approach to intraabdominal infections and select appropriate antimicrobial therapy

• Infectious issues in patients receiving TNF inhibitors
• Review the mechanism of action of TNF-alpha inhibitors. List infections associated with these agents

• Skin and soft tissue infections
• Recite common pathogens associated with skin infections
• Utilize appropriate antimicrobial therapy based on the exam

• C difficile and other diarrheas
• Recite common challenging aspects of treating diarrhea in the era of C difficile infection

• Infectious risks for international travelers
• Recite commonly encountered diseases associated with international travel
• Identify necessary items to bring for international travel

• Infectious Disease image review and word association (1-1.25 hrs)
• Recall specific infectious diseases based on keywords and/or images

• Our experience with CoV2
• Understand presentations for covid 19 as well as inpatient and outpatient treatment strategies, and vaccine indications

• Navigating challenges in patients diagnosed with mental illness: Infections, immunosuppression, and medical comorbidities that complicate treatment
• Describe the challenges associated with managing patients diagnosed with mental illness

• Addressing the challenges of Adverse Drug Reactions; identifying, reporting, and recognizing the benefits of benchmarking
• Identify the challenges of ADR reporting
• Improve understanding among clinicians about the importance of reporting adverse effects in patients under their care

• Clinical update on high alert medications, Beers list, FDA boxed warnings, and drug-drug interaction refresher
• Identify the challenges of using high-alert medications
• Apply clinical pearls to improve medication safety in patients diagnosed with mental illness

• Medical Cannabis: Clinical Considerations
• Review of the endocannabinoid system and how the medical cannabis system has evolved
• Recognize when medical cannabis is appropriate as a therapeutic option

• How to Authorize Medical Cannabis and Case Studies
• Understand how to authorize/prescribe medical cannabis and apply the knowledge gained to real cases